| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Head and Neck Neoplasms | 65 | 2022 | 2694 | 7.530 |
Why?
|
| Mouth Neoplasms | 18 | 2021 | 620 | 5.150 |
Why?
|
| Carcinoma, Squamous Cell | 39 | 2022 | 4020 | 4.030 |
Why?
|
| Tongue Neoplasms | 8 | 2021 | 179 | 3.770 |
Why?
|
| Otolaryngology | 14 | 2022 | 640 | 2.700 |
Why?
|
| Oropharyngeal Neoplasms | 10 | 2022 | 445 | 2.250 |
Why?
|
| Lingual Nerve | 3 | 2019 | 32 | 1.970 |
Why?
|
| Papillomavirus Infections | 13 | 2022 | 1472 | 1.960 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 8 | 2021 | 329 | 1.830 |
Why?
|
| Tongue | 9 | 2021 | 404 | 1.740 |
Why?
|
| Salivary Gland Neoplasms | 3 | 2020 | 295 | 1.730 |
Why?
|
| Surgical Flaps | 16 | 2021 | 1627 | 1.520 |
Why?
|
| Oral Surgical Procedures | 2 | 2021 | 162 | 1.380 |
Why?
|
| Reconstructive Surgical Procedures | 12 | 2021 | 2151 | 1.290 |
Why?
|
| Glossectomy | 5 | 2021 | 52 | 1.250 |
Why?
|
| Deglutition Disorders | 4 | 2021 | 565 | 1.130 |
Why?
|
| Hypoglossal Nerve | 2 | 2016 | 96 | 1.110 |
Why?
|
| Papillomaviridae | 7 | 2022 | 1131 | 1.080 |
Why?
|
| Mouth | 4 | 2021 | 413 | 1.070 |
Why?
|
| Tracheal Stenosis | 2 | 2017 | 224 | 1.030 |
Why?
|
| Neck Dissection | 4 | 2019 | 214 | 0.910 |
Why?
|
| Laryngeal Neoplasms | 4 | 2018 | 531 | 0.870 |
Why?
|
| African Americans | 7 | 2019 | 5194 | 0.850 |
Why?
|
| Ultrasonography | 6 | 2021 | 5913 | 0.850 |
Why?
|
| Larynx, Artificial | 2 | 2020 | 68 | 0.840 |
Why?
|
| Cross Infection | 2 | 2020 | 1411 | 0.820 |
Why?
|
| Laryngoplasty | 1 | 2020 | 51 | 0.810 |
Why?
|
| Alphapapillomavirus | 3 | 2022 | 223 | 0.800 |
Why?
|
| Marital Status | 2 | 2019 | 443 | 0.780 |
Why?
|
| Speech Disorders | 1 | 2021 | 182 | 0.770 |
Why?
|
| Ranula | 1 | 2019 | 11 | 0.760 |
Why?
|
| Tracheostomy | 2 | 2020 | 404 | 0.760 |
Why?
|
| Sexual Behavior | 3 | 2019 | 1866 | 0.740 |
Why?
|
| Papillomavirus Vaccines | 4 | 2022 | 480 | 0.740 |
Why?
|
| Free Tissue Flaps | 3 | 2021 | 279 | 0.730 |
Why?
|
| Survivors | 4 | 2018 | 2141 | 0.730 |
Why?
|
| Salivary Glands | 1 | 2020 | 233 | 0.730 |
Why?
|
| Marketing of Health Services | 1 | 2020 | 157 | 0.720 |
Why?
|
| Humans | 179 | 2022 | 709431 | 0.700 |
Why?
|
| Reimbursement, Incentive | 3 | 2020 | 525 | 0.700 |
Why?
|
| Scalp | 4 | 2016 | 375 | 0.670 |
Why?
|
| Neoplasm Staging | 12 | 2021 | 11244 | 0.670 |
Why?
|
| Cost Control | 1 | 2020 | 628 | 0.650 |
Why?
|
| Patient Advocacy | 1 | 2019 | 352 | 0.640 |
Why?
|
| Tracheotomy | 1 | 2018 | 167 | 0.640 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 258 | 0.630 |
Why?
|
| Medicare | 7 | 2021 | 5616 | 0.630 |
Why?
|
| State Government | 1 | 2020 | 368 | 0.630 |
Why?
|
| Insurance Coverage | 5 | 2020 | 1846 | 0.620 |
Why?
|
| Access to Information | 1 | 2020 | 307 | 0.620 |
Why?
|
| SEER Program | 10 | 2022 | 1556 | 0.610 |
Why?
|
| Neoplasms, Multiple Primary | 2 | 2018 | 631 | 0.600 |
Why?
|
| Mouth Mucosa | 2 | 2018 | 432 | 0.590 |
Why?
|
| Orbit | 3 | 2006 | 430 | 0.570 |
Why?
|
| Oropharynx | 1 | 2016 | 131 | 0.570 |
Why?
|
| Nose Neoplasms | 4 | 2021 | 249 | 0.570 |
Why?
|
| Analgesics, Opioid | 3 | 2021 | 3301 | 0.560 |
Why?
|
| Cytodiagnosis | 1 | 2019 | 414 | 0.560 |
Why?
|
| Postoperative Complications | 9 | 2021 | 15035 | 0.540 |
Why?
|
| Temporal Bone | 5 | 2008 | 669 | 0.540 |
Why?
|
| Retrospective Studies | 46 | 2022 | 71151 | 0.540 |
Why?
|
| Middle Aged | 81 | 2022 | 215428 | 0.540 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2018 | 373 | 0.540 |
Why?
|
| Aged | 67 | 2022 | 162592 | 0.530 |
Why?
|
| Male | 95 | 2022 | 351848 | 0.520 |
Why?
|
| Mandible | 2 | 2014 | 712 | 0.520 |
Why?
|
| Conflict of Interest | 1 | 2019 | 564 | 0.520 |
Why?
|
| Salvage Therapy | 4 | 2021 | 1298 | 0.510 |
Why?
|
| Health Status Disparities | 2 | 2015 | 1723 | 0.510 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2019 | 1063 | 0.500 |
Why?
|
| Pain, Postoperative | 2 | 2021 | 1598 | 0.500 |
Why?
|
| Cross-Sectional Studies | 14 | 2021 | 22944 | 0.500 |
Why?
|
| Myoblasts | 2 | 2006 | 263 | 0.490 |
Why?
|
| Ambulatory Care Facilities | 1 | 2020 | 879 | 0.490 |
Why?
|
| Coronavirus Infections | 3 | 2020 | 3163 | 0.490 |
Why?
|
| Deglutition | 3 | 2021 | 195 | 0.490 |
Why?
|
| Pneumonia, Viral | 3 | 2020 | 3276 | 0.480 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2021 | 1020 | 0.480 |
Why?
|
| Thyroid Cartilage | 4 | 2004 | 40 | 0.480 |
Why?
|
| Female | 91 | 2022 | 377269 | 0.470 |
Why?
|
| United States | 33 | 2022 | 67177 | 0.450 |
Why?
|
| Laryngectomy | 5 | 2020 | 234 | 0.450 |
Why?
|
| Inpatients | 2 | 2022 | 2183 | 0.450 |
Why?
|
| Cause of Death | 3 | 2018 | 3563 | 0.440 |
Why?
|
| Microsurgery | 3 | 2009 | 814 | 0.440 |
Why?
|
| Ophthalmologic Surgical Procedures | 2 | 2006 | 338 | 0.440 |
Why?
|
| Jugular Veins | 2 | 2021 | 219 | 0.430 |
Why?
|
| Drug Industry | 1 | 2019 | 908 | 0.430 |
Why?
|
| Quality of Life | 8 | 2021 | 11553 | 0.430 |
Why?
|
| Craniotomy | 1 | 2016 | 723 | 0.430 |
Why?
|
| Medicaid | 4 | 2020 | 2599 | 0.420 |
Why?
|
| Anemia | 2 | 2019 | 1383 | 0.420 |
Why?
|
| Skull | 1 | 2016 | 808 | 0.420 |
Why?
|
| Ear Neoplasms | 3 | 2008 | 123 | 0.410 |
Why?
|
| Pandemics | 3 | 2020 | 6922 | 0.410 |
Why?
|
| Life Expectancy | 1 | 2017 | 1119 | 0.410 |
Why?
|
| Awareness | 1 | 2015 | 600 | 0.410 |
Why?
|
| Neoplasm Recurrence, Local | 10 | 2021 | 8864 | 0.400 |
Why?
|
| Frozen Sections | 3 | 2020 | 170 | 0.400 |
Why?
|
| Trachea | 2 | 2015 | 1073 | 0.390 |
Why?
|
| Academic Medical Centers | 1 | 2021 | 2785 | 0.390 |
Why?
|
| Neoplasms, Second Primary | 2 | 2018 | 1010 | 0.390 |
Why?
|
| Survival Analysis | 8 | 2018 | 10603 | 0.380 |
Why?
|
| Lip | 2 | 2009 | 182 | 0.370 |
Why?
|
| Skull Base Neoplasms | 3 | 2008 | 276 | 0.370 |
Why?
|
| Carcinoma, Adenoid Cystic | 5 | 2022 | 262 | 0.360 |
Why?
|
| Adult | 54 | 2021 | 212298 | 0.360 |
Why?
|
| Disease-Free Survival | 8 | 2019 | 7078 | 0.350 |
Why?
|
| Health Knowledge, Attitudes, Practice | 5 | 2022 | 3946 | 0.350 |
Why?
|
| Surgical Wound Infection | 1 | 2018 | 1488 | 0.340 |
Why?
|
| Preoperative Care | 1 | 2018 | 2368 | 0.340 |
Why?
|
| Drug Prescriptions | 1 | 2018 | 1673 | 0.340 |
Why?
|
| Aged, 80 and over | 29 | 2022 | 58752 | 0.330 |
Why?
|
| Paranasal Sinus Neoplasms | 4 | 2021 | 241 | 0.330 |
Why?
|
| Otorhinolaryngologic Diseases | 1 | 2008 | 93 | 0.330 |
Why?
|
| Societies, Medical | 1 | 2019 | 3665 | 0.320 |
Why?
|
| Opioid-Related Disorders | 1 | 2021 | 1825 | 0.320 |
Why?
|
| Laryngostenosis | 2 | 2010 | 158 | 0.310 |
Why?
|
| Prognosis | 11 | 2021 | 29148 | 0.310 |
Why?
|
| Speech | 2 | 2021 | 483 | 0.300 |
Why?
|
| Internship and Residency | 4 | 2022 | 5527 | 0.300 |
Why?
|
| Thyroid Neoplasms | 2 | 2018 | 2214 | 0.300 |
Why?
|
| Bone Marrow Cells | 1 | 2014 | 2631 | 0.300 |
Why?
|
| Neoplasms | 6 | 2022 | 20421 | 0.300 |
Why?
|
| Stents | 2 | 2017 | 3299 | 0.290 |
Why?
|
| Nasal Cavity | 4 | 2021 | 308 | 0.290 |
Why?
|
| Patient Protection and Affordable Care Act | 3 | 2020 | 1160 | 0.290 |
Why?
|
| Orbital Diseases | 1 | 2006 | 191 | 0.260 |
Why?
|
| Radiotherapy, Adjuvant | 6 | 2020 | 1832 | 0.260 |
Why?
|
| Orbit Evisceration | 1 | 2003 | 11 | 0.260 |
Why?
|
| Microcirculation | 1 | 2009 | 1292 | 0.260 |
Why?
|
| Alcohol Drinking | 1 | 2017 | 3869 | 0.260 |
Why?
|
| Sex Factors | 6 | 2019 | 10744 | 0.250 |
Why?
|
| Treatment Outcome | 18 | 2021 | 61963 | 0.250 |
Why?
|
| Intensive Care Units | 1 | 2017 | 3422 | 0.250 |
Why?
|
| Pilot Projects | 4 | 2021 | 8036 | 0.250 |
Why?
|
| Coloring Agents | 2 | 2021 | 557 | 0.250 |
Why?
|
| Rectus Abdominis | 1 | 2003 | 97 | 0.250 |
Why?
|
| Reimbursement Mechanisms | 2 | 2020 | 663 | 0.240 |
Why?
|
| Carcinoma, Basal Cell | 5 | 2008 | 515 | 0.240 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 3 | 2013 | 344 | 0.240 |
Why?
|
| Laryngeal Diseases | 2 | 2020 | 246 | 0.240 |
Why?
|
| Depressive Disorder, Major | 2 | 2019 | 4470 | 0.230 |
Why?
|
| Phonation | 2 | 2020 | 212 | 0.230 |
Why?
|
| Fistula | 3 | 2012 | 213 | 0.230 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 4747 | 0.230 |
Why?
|
| Skin Neoplasms | 4 | 2016 | 5349 | 0.230 |
Why?
|
| Neoplasm Invasiveness | 6 | 2020 | 3740 | 0.220 |
Why?
|
| Forearm | 4 | 2016 | 408 | 0.220 |
Why?
|
| Fascia | 2 | 2000 | 134 | 0.220 |
Why?
|
| Communication | 1 | 2016 | 3395 | 0.220 |
Why?
|
| Bone Neoplasms | 1 | 2014 | 2568 | 0.220 |
Why?
|
| Facial Neoplasms | 2 | 2002 | 131 | 0.220 |
Why?
|
| Rats, Wistar | 2 | 2016 | 2012 | 0.220 |
Why?
|
| Reoperation | 4 | 2018 | 4155 | 0.220 |
Why?
|
| Adenocarcinoma | 3 | 2018 | 6462 | 0.210 |
Why?
|
| Eye Diseases | 1 | 2006 | 650 | 0.210 |
Why?
|
| Cricoid Cartilage | 2 | 2015 | 73 | 0.210 |
Why?
|
| Socioeconomic Factors | 4 | 2019 | 7740 | 0.210 |
Why?
|
| Pharyngectomy | 1 | 2000 | 45 | 0.200 |
Why?
|
| Parotid Neoplasms | 2 | 2019 | 161 | 0.200 |
Why?
|
| Endocrine Surgical Procedures | 1 | 2020 | 30 | 0.200 |
Why?
|
| Intraoperative Period | 2 | 2021 | 547 | 0.200 |
Why?
|
| Prostheses and Implants | 3 | 2000 | 1330 | 0.200 |
Why?
|
| Smoking | 2 | 2017 | 8940 | 0.200 |
Why?
|
| Preoperative Period | 2 | 2021 | 556 | 0.200 |
Why?
|
| Logistic Models | 5 | 2020 | 13622 | 0.200 |
Why?
|
| Relative Value Scales | 1 | 2020 | 87 | 0.200 |
Why?
|
| Postoperative Care | 3 | 2020 | 1513 | 0.200 |
Why?
|
| Fee Schedules | 1 | 2020 | 87 | 0.200 |
Why?
|
| Intubation | 1 | 2000 | 138 | 0.200 |
Why?
|
| Risk Assessment | 6 | 2021 | 23519 | 0.200 |
Why?
|
| Adenoviruses, Human | 2 | 2014 | 275 | 0.190 |
Why?
|
| Epistaxis | 1 | 2000 | 109 | 0.190 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2015 | 4282 | 0.190 |
Why?
|
| Positron-Emission Tomography | 2 | 2013 | 6123 | 0.190 |
Why?
|
| Sphenoid Bone | 1 | 2000 | 171 | 0.190 |
Why?
|
| Toll-Like Receptor 8 | 3 | 2014 | 92 | 0.190 |
Why?
|
| Neoplasm Metastasis | 4 | 2019 | 5168 | 0.190 |
Why?
|
| Nose | 2 | 2020 | 487 | 0.190 |
Why?
|
| Skull Neoplasms | 2 | 2007 | 177 | 0.190 |
Why?
|
| Economics, Hospital | 1 | 2021 | 196 | 0.180 |
Why?
|
| Mandibular Neoplasms | 1 | 2000 | 132 | 0.180 |
Why?
|
| Young Adult | 13 | 2021 | 56163 | 0.180 |
Why?
|
| Illinois | 1 | 2019 | 116 | 0.180 |
Why?
|
| Prospective Payment System | 1 | 2020 | 135 | 0.180 |
Why?
|
| Insurance, Health | 4 | 2020 | 2483 | 0.180 |
Why?
|
| Cohort Studies | 10 | 2022 | 39650 | 0.180 |
Why?
|
| Carcinoma, Mucoepidermoid | 1 | 2019 | 98 | 0.180 |
Why?
|
| Research Report | 1 | 2022 | 358 | 0.170 |
Why?
|
| Dissection | 2 | 2019 | 278 | 0.170 |
Why?
|
| Momordica charantia | 1 | 2017 | 6 | 0.170 |
Why?
|
| 4-Nitroquinoline-1-oxide | 1 | 2017 | 18 | 0.170 |
Why?
|
| Managed Competition | 1 | 2018 | 34 | 0.170 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2021 | 20307 | 0.170 |
Why?
|
| Multivariate Analysis | 3 | 2018 | 12517 | 0.170 |
Why?
|
| Immune System Phenomena | 1 | 2017 | 16 | 0.170 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2015 | 1088 | 0.170 |
Why?
|
| Phototherapy | 1 | 2021 | 344 | 0.170 |
Why?
|
| Nasal Mucosa | 1 | 2021 | 368 | 0.170 |
Why?
|
| Carotid Artery, Common | 2 | 2009 | 191 | 0.170 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2019 | 214 | 0.170 |
Why?
|
| Vocal Cord Paralysis | 3 | 2000 | 250 | 0.170 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2018 | 104 | 0.170 |
Why?
|
| Hematocrit | 1 | 2019 | 639 | 0.170 |
Why?
|
| Carotid Artery, Internal | 1 | 2000 | 474 | 0.160 |
Why?
|
| Models, Educational | 1 | 2020 | 396 | 0.160 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2020 | 413 | 0.160 |
Why?
|
| CD4-Positive T-Lymphocytes | 4 | 2015 | 4402 | 0.160 |
Why?
|
| Skin Transplantation | 2 | 2000 | 1128 | 0.160 |
Why?
|
| Regression Analysis | 3 | 2017 | 6515 | 0.160 |
Why?
|
| Aerosols | 1 | 2020 | 692 | 0.160 |
Why?
|
| Adenoidectomy | 1 | 2018 | 168 | 0.160 |
Why?
|
| Specialties, Surgical | 1 | 2022 | 386 | 0.160 |
Why?
|
| Immunization Schedule | 1 | 2018 | 221 | 0.160 |
Why?
|
| Cutaneous Fistula | 2 | 2012 | 84 | 0.160 |
Why?
|
| Financing, Government | 1 | 2021 | 484 | 0.160 |
Why?
|
| Suicide | 2 | 2018 | 1559 | 0.160 |
Why?
|
| Medically Uninsured | 2 | 2020 | 860 | 0.160 |
Why?
|
| Dentigerous Cyst | 1 | 1996 | 21 | 0.160 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2022 | 450 | 0.160 |
Why?
|
| Maxillary Diseases | 1 | 1996 | 53 | 0.150 |
Why?
|
| Regeneration | 1 | 2006 | 1550 | 0.150 |
Why?
|
| Face | 2 | 2002 | 965 | 0.150 |
Why?
|
| Liver Function Tests | 1 | 2018 | 537 | 0.150 |
Why?
|
| Physician Incentive Plans | 1 | 2018 | 174 | 0.150 |
Why?
|
| Esophagectomy | 1 | 2000 | 465 | 0.150 |
Why?
|
| Plant Extracts | 2 | 2017 | 462 | 0.150 |
Why?
|
| Facial Nerve | 1 | 1999 | 271 | 0.150 |
Why?
|
| Survival Rate | 9 | 2021 | 13363 | 0.150 |
Why?
|
| Odds Ratio | 3 | 2019 | 10019 | 0.150 |
Why?
|
| Reference Standards | 1 | 2019 | 890 | 0.150 |
Why?
|
| Granuloma, Laryngeal | 1 | 1995 | 8 | 0.150 |
Why?
|
| Vaccination | 2 | 2018 | 2847 | 0.150 |
Why?
|
| Age Factors | 4 | 2018 | 18954 | 0.150 |
Why?
|
| Tonsillar Neoplasms | 1 | 1996 | 54 | 0.150 |
Why?
|
| Mastication | 1 | 2015 | 49 | 0.150 |
Why?
|
| Blood Chemical Analysis | 1 | 2018 | 467 | 0.140 |
Why?
|
| Adolescent | 19 | 2020 | 85327 | 0.140 |
Why?
|
| Fluorodeoxyglucose F18 | 3 | 2013 | 1994 | 0.140 |
Why?
|
| Tonsillectomy | 1 | 2018 | 271 | 0.140 |
Why?
|
| Kidney Function Tests | 1 | 2018 | 706 | 0.140 |
Why?
|
| Neck Muscles | 1 | 2015 | 106 | 0.140 |
Why?
|
| Granuloma, Foreign-Body | 1 | 1995 | 48 | 0.140 |
Why?
|
| Databases, Factual | 5 | 2019 | 7801 | 0.140 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2015 | 169 | 0.140 |
Why?
|
| Thigh | 1 | 2016 | 233 | 0.140 |
Why?
|
| Paranasal Sinus Diseases | 2 | 2012 | 130 | 0.140 |
Why?
|
| Wrist | 1 | 1996 | 207 | 0.140 |
Why?
|
| Rats | 5 | 2016 | 25068 | 0.140 |
Why?
|
| Cell Line, Tumor | 11 | 2022 | 17087 | 0.140 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2013 | 3047 | 0.140 |
Why?
|
| Rats, Inbred Lew | 3 | 2006 | 1154 | 0.140 |
Why?
|
| Disease Transmission, Infectious | 1 | 2020 | 548 | 0.140 |
Why?
|
| Laryngeal Nerves | 1 | 1994 | 59 | 0.130 |
Why?
|
| Pharyngeal Muscles | 1 | 1994 | 73 | 0.130 |
Why?
|
| Sexual Partners | 1 | 2019 | 688 | 0.130 |
Why?
|
| Polytetrafluoroethylene | 1 | 1995 | 254 | 0.130 |
Why?
|
| Spiral Ganglion | 1 | 2015 | 164 | 0.130 |
Why?
|
| Cucurbitaceae | 1 | 2013 | 5 | 0.130 |
Why?
|
| Office Visits | 1 | 2019 | 631 | 0.130 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2018 | 569 | 0.130 |
Why?
|
| Betapapillomavirus | 1 | 2013 | 6 | 0.130 |
Why?
|
| Proportional Hazards Models | 3 | 2019 | 12442 | 0.130 |
Why?
|
| Fluorescent Dyes | 1 | 2022 | 1990 | 0.130 |
Why?
|
| Hospitals, University | 1 | 2015 | 586 | 0.130 |
Why?
|
| Prosthesis Design | 1 | 2020 | 2135 | 0.130 |
Why?
|
| Carotid Artery Diseases | 1 | 2000 | 924 | 0.130 |
Why?
|
| Adenovirus E1A Proteins | 1 | 2013 | 91 | 0.120 |
Why?
|
| Hand Strength | 1 | 1996 | 450 | 0.120 |
Why?
|
| Paralysis | 1 | 1994 | 234 | 0.120 |
Why?
|
| Independent Living | 1 | 2017 | 530 | 0.120 |
Why?
|
| Tumor Microenvironment | 5 | 2017 | 2963 | 0.120 |
Why?
|
| Incidence | 4 | 2019 | 20587 | 0.120 |
Why?
|
| Internationality | 1 | 2019 | 1001 | 0.120 |
Why?
|
| Prevalence | 3 | 2019 | 14849 | 0.120 |
Why?
|
| Down-Regulation | 3 | 2018 | 3125 | 0.120 |
Why?
|
| Vascular Surgical Procedures | 1 | 2002 | 1509 | 0.120 |
Why?
|
| Neck | 4 | 2021 | 697 | 0.120 |
Why?
|
| Lymphoma | 1 | 2002 | 1908 | 0.120 |
Why?
|
| Chondroblastoma | 1 | 1992 | 51 | 0.120 |
Why?
|
| Fellowships and Scholarships | 1 | 2020 | 964 | 0.110 |
Why?
|
| Risk-Taking | 1 | 2018 | 986 | 0.110 |
Why?
|
| Delayed Diagnosis | 1 | 2015 | 410 | 0.110 |
Why?
|
| Bone Resorption | 1 | 1996 | 747 | 0.110 |
Why?
|
| Cranial Irradiation | 1 | 2015 | 436 | 0.110 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 15316 | 0.110 |
Why?
|
| Healthcare Disparities | 2 | 2018 | 2987 | 0.110 |
Why?
|
| Oncolytic Virotherapy | 2 | 2014 | 442 | 0.110 |
Why?
|
| Health Care Reform | 1 | 2021 | 1255 | 0.110 |
Why?
|
| Incidental Findings | 3 | 2011 | 675 | 0.110 |
Why?
|
| Oncogene Proteins, Viral | 1 | 2013 | 387 | 0.110 |
Why?
|
| Lymphatic Metastasis | 1 | 2019 | 2992 | 0.110 |
Why?
|
| Cannabis | 1 | 2016 | 326 | 0.100 |
Why?
|
| Motivation | 1 | 2020 | 1866 | 0.100 |
Why?
|
| Coculture Techniques | 4 | 2018 | 1382 | 0.100 |
Why?
|
| Neurosurgical Procedures | 1 | 2002 | 1990 | 0.100 |
Why?
|
| Case-Control Studies | 5 | 2022 | 21874 | 0.100 |
Why?
|
| Intracranial Aneurysm | 1 | 2000 | 1335 | 0.100 |
Why?
|
| Transcription Factors | 2 | 2022 | 11982 | 0.100 |
Why?
|
| Cell Cycle Proteins | 1 | 2022 | 3513 | 0.100 |
Why?
|
| Hospitalization | 2 | 2020 | 9632 | 0.100 |
Why?
|
| Students, Medical | 1 | 2022 | 1734 | 0.100 |
Why?
|
| Tissue Engineering | 3 | 2006 | 1846 | 0.100 |
Why?
|
| Time Factors | 5 | 2021 | 41295 | 0.090 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2013 | 629 | 0.090 |
Why?
|
| Registries | 3 | 2020 | 8019 | 0.090 |
Why?
|
| Combined Modality Therapy | 4 | 2021 | 8941 | 0.090 |
Why?
|
| Animals | 18 | 2020 | 170647 | 0.090 |
Why?
|
|